Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus
25 May 2019 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
University Hospital Costa del Sol, Marbella (Spain)
10 More presentations in this session
Access the full session
The Event
Heart Failure 2019
25 May 2019
08:30 CET
/f/125658/640x360/c39f4547b4/ett-s3-ep7.jpg)
